ArticleJournal of pharmacokinetics and pharmacodynamics2024

Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension.

Janneke M Brussee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.